Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
iShares Core US Aggregate Bond ETF
AGG
$137B
| $15.9M | 0.01% |
159,670
+158,412
| +12,592% | +$15.7M |
|
952
PUT
Macy's
M
$6.53B
| $15.9M | 0.01% |
906,600
-232,000
| -20% | -$4.91M |
|
953
Rivian
RIVN
$22B
| $15.8M | 0.01% |
1,023,796
+232,001
| +29% | +$3.92M |
|
954
PUT
First Solar
FSLR
$22.7B
| $15.8M | 0.01% |
72,800
-327,400
| -82% | -$59.8M |
|
955
CACI
CACI
$11B
| $15.8M | 0.01% |
53,436
+21,816
| +69% | +$6.43M |
|
956
Teva Pharmaceuticals
TEVA
$40.8B
| $15.8M | 0.01% |
1,784,945
+782,101
| +78% | +$7.73M |
|
957
HEICO Corp
HEI
$49.8B
| $15.7M | 0.01% |
91,552
+48,639
| +113% | +$8.19M |
|
958
Zebra Technologies
ZBRA
$14B
| $15.6M | 0.01% |
49,183
-20,009
| -29% | -$6.05M |
|
959
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
| $15.6M | 0.01% |
293,846
-131,311
| -31% | -$7.15M |
|
960
Royalty Pharma
RPRX
$25.9B
| $15.6M | 0.01% |
433,461
+31,271
| +8% | +$1.16M |
|
|
961
CALL
ExxonMobil
XOM
$644B
| $15.6M | 0.01% |
142,200
-427,000
| -75% | -$47.2M |
|
962
Packaging Corp of America
PKG
$21.9B
| $15.6M | 0.01% |
112,146
-145,373
| -56% | -$19.8M |
|
963
CALL
Comcast
CMCSA
$85B
| $15.4M | 0.01% |
407,400
-639,600
| -61% | -$24.2M |
|
964
PUT
Range Resources
RRC
$9.38B
| $15.4M | 0.01% |
583,300
+356,100
| +157% | +$8.97M |
|
965
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $15.4M | 0.01% |
258,980
-125,920
| -33% | -$7.48M |
|
966
Eagle Materials
EXP
$6.29B
| $15.4M | 0.01% |
104,915
+739
| +0.7% | +$105K |
|
|
967
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $15.4M | 0.01% |
202,000
-38,900
| -16% | -$3.23M |
|
968
CEMIG Preferred Shares
CIG
$6.26B
| $15.3M | 0.01% |
8,898,275
| – | – |
|
|
UNVR
969
DELISTED
Univar Solutions Inc.
UNVR
| $15.3M | 0.01% |
435,863
+383,793
| +737% | +$13M |
|
970
CALL
Ford
F
$58.5B
| $15.2M | 0.01% |
1,210,000
-2,997,000
| -71% | -$37.5M |
|
971
CALL
AbbVie
ABBV
$443B
| $15.2M | 0.01% |
95,400
-158,100
| -62% | -$24.2M |
|
972
Interactive Brokers
IBKR
$39.2B
| $15.1M | 0.01% |
733,080
+202,968
| +38% | +$4.13M |
|
973
Denali Therapeutics
DNLI
$3.65B
| $15.1M | 0.01% |
656,427
+70,462
| +12% | +$1.94M |
|
974
Snap-on
SNA
$21.2B
| $15M | 0.01% |
60,865
-26,769
| -31% | -$6.54M |
|
975
Bunge Global
BG
$20.4B
| $15M | 0.01% |
156,849
+29,602
| +23% | +$2.88M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.